Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	3428	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	3948	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	4092	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	5051	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	5193	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	5425	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	5437	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	6193	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	6336	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	6379	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	6543	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	6558	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	6767	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	6900	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	6966	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	7121	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	7159	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	7248	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	7394	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	7408	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	7501	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	7552	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	7623	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	7982	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	8189	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	8305	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	8499	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	8543	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	8664	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	8779	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	8798	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	9096	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	9347	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	9563	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	9590	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	9614	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	9689	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	9708	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	9873	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	10101	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	10152	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	10163	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	10226	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	10436	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	10513	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	10515	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	10831	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	10913	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	11095	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	11666	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	11790	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	11815	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	11856	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	12098	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	12270	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	12605	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	12648	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	12750	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	12795	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	12898	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	13050	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	13434	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	13607	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	13915	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	15113	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	15446	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	15847	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	16046	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	16486	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	16599	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	17801	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	17877	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	18399	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	18438	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	20004	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	20985	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	21905	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	22024	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	22716	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	25162	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	27259	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	27437	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+	31262	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	NICOTINAMIDE (CAS# 98-92-0); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	N